Mindset Pharma Stock Current Asset
| MSSTFDelisted Stock | USD 0.36 0.00 0.00% |
Mindset Pharma fundamentals help investors to digest information that contributes to Mindset Pharma's financial success or failures. It also enables traders to predict the movement of Mindset OTC Stock. The fundamental analysis module provides a way to measure Mindset Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mindset Pharma otc stock.
Mindset |
Mindset Pharma OTC Stock Current Asset Analysis
Mindset Pharma's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
CompetitionIn accordance with the recently published financial statements, Mindset Pharma has a Current Asset of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Mindset Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mindset Pharma's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Mindset Pharma could also be used in its relative valuation, which is a method of valuing Mindset Pharma by comparing valuation metrics of similar companies.Mindset Pharma is currently under evaluation in current asset category among its peers.
Mindset Fundamentals
| Return On Equity | -2.43 | |||
| Return On Asset | -0.48 | |||
| Profit Margin | (1.64) % | |||
| Operating Margin | (1.33) % | |||
| Current Valuation | 19.22 M | |||
| Shares Outstanding | 95.25 M | |||
| Shares Owned By Insiders | 9.00 % | |||
| Shares Owned By Institutions | 0.88 % | |||
| Price To Book | 28.87 X | |||
| Price To Sales | 4.83 X | |||
| Revenue | 3.91 M | |||
| Gross Profit | 3.91 M | |||
| EBITDA | (16.53 M) | |||
| Net Income | (16.61 M) | |||
| Cash And Equivalents | 8.71 M | |||
| Cash Per Share | 0.09 X | |||
| Total Debt | 171.79 K | |||
| Debt To Equity | 0.12 % | |||
| Current Ratio | 1.18 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | 385.56 K | |||
| Earnings Per Share | (0.19) X | |||
| Target Price | 5.02 | |||
| Beta | -0.28 | |||
| Market Capitalization | 20.95 M | |||
| Total Asset | 9.77 M | |||
| Z Score | 69.3 | |||
| Net Asset | 9.77 M |
About Mindset Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mindset Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mindset Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mindset Pharma based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Mindset OTC Stock
If you are still planning to invest in Mindset Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mindset Pharma's history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Correlations Find global opportunities by holding instruments from different markets |